Model identification of gas antisolvent crystallization of aspirin using nucleation, growth, and agglomeration kinetics
- 26 August 2025
- journal article
- research article
- Published by Springer Nature in Reaction Kinetics, Mechanisms and Catalysis
- Vol. 138 (6) , 3745-3763
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- CO2 utilization as gas antisolvent for the pharmaceutical micro and nanoparticle production: A reviewArabian Journal of Chemistry, 2022
- Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs)Advanced Drug Delivery Reviews, 2021
- Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals – A comprehensive reviewAdvanced Drug Delivery Reviews, 2018
- Formation of indomethacin–saccharin cocrystals using supercritical fluid technologyEuropean Journal of Pharmaceutical Sciences, 2009
- A discretized population balance for particle formation from gas antisolvent process: The combined Lax-Wendroff and Crank-Nicholson methodComputers & Chemical Engineering, 2009
- An interpretation of the metastable zone width concerning primary nucleation in anti-solvent crystallizationJournal of Crystal Growth, 2008
- Antisolvent crystallization: Model identification, experimental validation and dynamic simulationChemical Engineering Science, 2008
- Kinetics of magnesium hydroxide precipitation from sea bitternChemical Engineering and Processing - Process Intensification, 2008
- Kinetics of particle formation in the gas antisolvent precipitation processAIChE Journal, 2003
- PARTICULATE PROCESSES1988